Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Anavex Life Sciences Corp. (AVXL) had Current Assets of $103.81M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$10.84M |
|
$-10.84M |
|
$1.02M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-9.83M |
|
$-10.84M |
|
$-10.84M |
|
85.29M |
|
85.29M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
|
Current Assets |
$103.81M |
-- |
|
-- |
|
$103.81M |
|
$8.95M |
|
-- |
|
-- |
|
$8.95M |
|
$94.87M |
|
$94.87M |
|
$94.87M |
|
86.67M |
|
| Cash Flow Statement Financials | |
$-39.04M |
|
-- |
|
$9.43M |
|
$132.19M |
|
$102.58M |
|
$-29.61M |
|
$11.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.04M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.36% |
|
-10.36% |
|
-9.47% |
|
-10.36% |
|
$1.09 |
|
$-0.46 |
|
$-0.46 |
|